Related Experiment Video
Updated: Jun 4, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
[Cancer genome analysis through next-generation sequencing]
1Research Center for Advanced Science and Technology, University of Tokyo.
Abstract:
Cancers are caused by the accumulation of genomic and epigenomic alterations. Particularly, genetic alterations, such as BCR-ABL translocation and EGFR mutation, which are present only in cancer cells, are the best therapeutic targets to date. The application of next-generation DNA sequencing technologies, including whole-genome, whole-exome and whole-transcriptome approaches, has brought substantial advances in cancer genomics. These methods will increase the efficiency and resolution of detection of somatic cancer genome alterations, including nucleotide substitutions, small insertions and deletions, copy number alterations, and chromosomal rearrangements. Currently, an international network of cancer genome projects was launched to coordinate large-scale cancer genome studies. The greatest impact of next-generation sequencing of cancer genomes in the near future will be in cancer diagnostics. To provide personalized cancer treatment, development of accurate genetic diagnostic tests and biomarkers is required and will surely be accelerated by next-generation sequencing technology.
Insights
Next-generation sequencing advances cancer genomics by improving detection of somatic alterations. This technology is crucial for developing precise diagnostic tests and personalized cancer treatments.
Area of Science:
- Genomic medicine
- Cancer genomics
- Molecular diagnostics
Context:
- Cancer arises from accumulated genomic and epigenomic alterations.
- Specific genetic alterations like BCR-ABL translocation and EGFR mutations are key therapeutic targets.
- Next-generation sequencing (NGS) technologies have revolutionized cancer genomics.
Purpose:
- To highlight the advancements in cancer genomics driven by next-generation sequencing.
- To emphasize the role of NGS in detecting various somatic cancer genome alterations.
- To discuss the future impact of NGS on cancer diagnostics and personalized treatment.
Summary:
- NGS technologies, including whole-genome, whole-exome, and whole-transcriptome sequencing, enhance the detection of somatic alterations.
- These alterations include nucleotide substitutions, small insertions/deletions, copy number variations, and chromosomal rearrangements.
- International cancer genome projects are coordinating large-scale studies.
Impact:
- NGS is poised to significantly impact cancer diagnostics, enabling more accurate genetic tests.
- The technology will accelerate the development of biomarkers for personalized cancer therapy.
- Improved detection of cancer genome alterations facilitates targeted treatment strategies.
Related Concept Videos
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Genomics
Sanger Sequencing
Cancers Originate from Somatic Mutations in a Single Cell

